piracetam has been researched along with Central Nervous System Origin Vertigo in 17 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo." | 9.20 | Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial. ( Avcu, N; Doğan, NÖ; Pekdemir, M; Yaka, E; Yılmaz, S, 2015) |
| "The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 9.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
| "This subanalysis compared the efficacy of betahistine plus piracetam dual therapy versus betahistine monotherapy using data from OSVaLD, a 3 month, open-label, observational study conducted in 2272 patients with peripheral vestibular vertigo." | 7.81 | Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study. ( Lilenko, SV; Melnikov, OA; Nauta, J; Ouwens, MJ, 2015) |
| "A pilot study with piracetam (Nootropil; UCB) was performed in 5 selected dizzy patients who had a diagnosis of presbyvertigo or vertebrobasilar insufficiency." | 7.67 | The use of piracetam in vertigo. ( Fernandes, CM; Samuel, J, 1985) |
| "Piracetam was found to have a significant effect on the first three." | 6.65 | The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. ( Oosterveld, WJ, 1980) |
| "Piracetam has been shown to be effective in vertigo of both central and peripheral origin." | 6.40 | The effectiveness of piracetam in vertigo. ( Oosterveld, WJ, 1999) |
| "The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo." | 5.20 | Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial. ( Avcu, N; Doğan, NÖ; Pekdemir, M; Yaka, E; Yılmaz, S, 2015) |
| "The effect of piracetam, a cyclical derivative of GABA, was compared with that of a placebo in a double-blind study of 60 patients with post-concussional syndrome of 2-12 months' duration." | 5.04 | Piracetam in the treatment of post-concussional syndrome. A double-blind study. ( Hakamies, L; Hakkarainen, H, 1978) |
| "This subanalysis compared the efficacy of betahistine plus piracetam dual therapy versus betahistine monotherapy using data from OSVaLD, a 3 month, open-label, observational study conducted in 2272 patients with peripheral vestibular vertigo." | 3.81 | Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study. ( Lilenko, SV; Melnikov, OA; Nauta, J; Ouwens, MJ, 2015) |
| "A pilot study with piracetam (Nootropil; UCB) was performed in 5 selected dizzy patients who had a diagnosis of presbyvertigo or vertebrobasilar insufficiency." | 3.67 | The use of piracetam in vertigo. ( Fernandes, CM; Samuel, J, 1985) |
| "Piracetam was found to have a significant effect on the first three." | 2.65 | The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin. ( Oosterveld, WJ, 1980) |
| "Piracetam has been shown to be effective in vertigo of both central and peripheral origin." | 2.40 | The effectiveness of piracetam in vertigo. ( Oosterveld, WJ, 1999) |
| "The migraine--a benign paroxysmal vertigo of childhood complex is the most frequent etiology of pediatric dizziness, with an incidence of 34." | 1.30 | The migraine: benign paroxysmal vertigo of childhood complex. ( Arroyo, R; Calvin, FJ; de Lucas, P; Herraiz, C; Tapia, MC, 1999) |
| "Hemorheological Treatment in Vertigo." | 1.28 | [Hemorheologic therapy of asystematic vertigo]. ( Angelkort, B; Dehnert, HG; Spürk, P, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (41.18) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 2 (11.76) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Molnár, A | 1 |
| Maihoub, S | 1 |
| Tamás, L | 1 |
| Szirmai, Á | 1 |
| Doğan, NÖ | 1 |
| Avcu, N | 1 |
| Yaka, E | 1 |
| Yılmaz, S | 1 |
| Pekdemir, M | 1 |
| Melnikov, OA | 1 |
| Lilenko, SV | 1 |
| Nauta, J | 1 |
| Ouwens, MJ | 1 |
| Olszewski, J | 1 |
| Repetowski, M | 1 |
| Kuśmierczyk, K | 1 |
| Mantsev, EI | 1 |
| Sigaleva, EE | 1 |
| Winblad, B | 1 |
| Oosterveld, WJ | 2 |
| Pons Rocher, F | 1 |
| Herraiz, C | 1 |
| Calvin, FJ | 1 |
| Tapia, MC | 1 |
| de Lucas, P | 1 |
| Arroyo, R | 1 |
| Wieck, HH | 1 |
| Hakkarainen, H | 1 |
| Hakamies, L | 1 |
| Spürk, P | 1 |
| Dehnert, HG | 1 |
| Angelkort, B | 1 |
| Ordosgoitia, H | 1 |
| Castro, C | 1 |
| Carbayeda, M | 1 |
| Labella, T | 1 |
| Claussen, CF | 1 |
| Schneider, D | 1 |
| Patil, NP | 1 |
| Miszke, A | 1 |
| Rapacz, K | 1 |
| Fernandes, CM | 1 |
| Samuel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Efficacy Between Piracetam and Dimenhydrinate in Patients With Peripheral Vertigo: A Double Blind Randomized Clinical Trial[NCT01890538] | Phase 4 | 94 participants (Actual) | Interventional | 2013-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for piracetam and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Piracetam: a review of pharmacological properties and clinical uses.
Topics: Anemia, Sickle Cell; Animals; Cerebrovascular Circulation; Cognition Disorders; Drug Evaluation; Dys | 2005 |
The effectiveness of piracetam in vertigo.
Topics: Controlled Clinical Trials as Topic; Humans; Neuroprotective Agents; Piracetam; Treatment Outcome; V | 1999 |
7 trials available for piracetam and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial.
Topics: Administration, Intravenous; Adult; Aged; Antiemetics; Dimenhydrinate; Double-Blind Method; Emergenc | 2015 |
[Comparative assessment of results in cervical vertigo pharmacotherapy vs physiotherapy treatment].
Topics: Adult; Aged; Aged, 80 and over; Betahistine; Cervical Vertebrae; Female; Humans; Male; Middle Aged; | 2007 |
The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Pirac | 1980 |
[The effect of pharmacological treatment in the compensation of vertigo].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Child; Dihydroergotoxine; Dose-Response Relat | 1999 |
Piracetam in the treatment of post-concussional syndrome. A double-blind study.
Topics: Brain Concussion; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Fatigue; Headache; | 1978 |
The treatment of minocycline-induced brainstem vertigo by the combined administration of piracetam and ergotoxin.
Topics: Adult; Brain Stem; Double-Blind Method; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Femal | 1989 |
[Treatment of vertigo syndrome with Nootropil].
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Pirac | 1988 |
8 other studies available for piracetam and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
Conservative Treatment Possibilities of Ménière Disease, Involving Vertigo Diaries.
Topics: Betahistine; Conservative Treatment; Drug Therapy, Combination; Female; Humans; Male; Medical Record | 2021 |
Betahistine plus piracetam dual therapy versus betahistine monotherapy for peripheral vestibular vertigo: a confounder-corrected subanalysis of the OSVaLD study.
Topics: Adult; Aged; Betahistine; Dizziness; Female; Humans; Male; Middle Aged; Odds Ratio; Piracetam; Vasod | 2015 |
[Efficacy of piracetam in vertigo].
Topics: Humans; Nootropic Agents; Piracetam; Treatment Outcome; Vertigo; Vestibule, Labyrinth | 2009 |
The migraine: benign paroxysmal vertigo of childhood complex.
Topics: Adolescent; Child; Child, Preschool; Diazepam; Dizziness; Female; Humans; Infant; Male; Migraine Dis | 1999 |
[Therapy with cerebral anti-hypoxidotics].
Topics: Humans; Hypnotics and Sedatives; Hypoxia, Brain; Meclofenoxate; Piracetam; Tranquilizing Agents; Vas | 1979 |
[Hemorheologic therapy of asystematic vertigo].
Topics: Adult; Aged; Aged, 80 and over; Carotid Stenosis; Female; Hematocrit; Hemodilution; Humans; Hydroxye | 1991 |
[Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
Topics: Adult; Aged; Dihydroergotoxine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pirace | 1989 |
The use of piracetam in vertigo.
Topics: Aged; Dizziness; Electronystagmography; Female; Humans; Male; Middle Aged; Pilot Projects; Piracetam | 1985 |